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The European Environment and Health Strategy adopted
by the European Commission in 2003 presented a new
vision on how to address environment and health in an
integrated way by putting health in the centre of environ-
mental policy. Based upon the Strategy the Commission
adopted in 2004 a Communication on the Environment
and Health Action Plan 2004 – 2010. In Action 3 of this
Action Plan the European Commission announced to
develop a coherent approach to Human Biomonitoring in
Europe in close cooperation with the Member States.
The first step (2004–2006) in implementation of Action 3
consisted of the technical preparation of the European
Pilot Project. For this reason the EU Commission
launched the ESBIO (Expert team to support biomonitor-
ing in Europe) project, scheduled for 2006 and 2007. The
project team consisted of nearly all members of the Imple-
mentation Group on Human Biomonitoring.
ESBIO aimed to identify and analyse major ethical prob-
lems related to individualised human biomonitoring
(HBM) as part of the preparatory work of ESBIO of initi-
ating a European human biomonitoring pilot project. The
workshop in Copenhagen was part of the deliverables of
ESBIO, which is further described in the presentations of
Smolders et al. [1] and Thomsen et al [2]. The workshop
provided two days of debate on identifying major items
for guidelines for ethical issues and communication in
human biomonitoring. Almost 50 participants from most
European countries and US attended the workshop and
represented stakeholders of industry, regulators, academia
and animal welfare. This special issue of Environmental
Health includes manuscripts from some of the presenters
at the workshop while Philippe Grandjean's presentation
is published [3] as well as the presentation by Uffe Lind
[4].
Survey on ethics
ESBIO performed a survey on the general ethical proce-
dures related to individualised human biomonitoring
through questionnaires for stakeholders within biomoni-
toring forwarded to ESBIO members for supplementary
information. A Danish template was used and inputs were
received from Germany, Belgium, United Kingdom, Swe-
den, France, Luxembourg, Italy, Estonia, Czech Republic,
Slovakia, Portugal and Cyprus. The questionnaires
revealed common rules and procedures but also some dif-
ferences related to extent of information, public involve-
ment and feed back. The results from the survey are
available on the ESBIO webpage as the report [5].
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The legal situation in a number of countries regarding Eth-
ics committees and data protection was extracted from
existing data in Privireal (Privacy in Research Ethics and
Law) database [6] and tables with information about
country specific regulation were developed and sent for
approval to key persons in each country of Denmark,
Estonia, France, Germany, Ireland, Lithuania, Nether-
lands, Poland, Portugal, Slovak Republic, Spain, Sweden,
United Kingdom. These pages are available on the ESBIO
webpage [5] and examples of practices in Poland [7] are
provided in this supplement issue of Environmental
Health. The supplement issue also include ethics issues
experienced in HBM within Portuguese health surveil-
lance [8].
Principles of research ethics
Research Ethics is based on the Nuremberg Code, which
are ten standards to which physicians shall conform when
carrying out experiments on human subject. The code was
laid down by the war crimes tribunal after 2nd World War
[9]. The Helsinki Declaration followed the Nuremberg
Code in June 1964 and acts as a guideline for the con-
tracted states of the World Medical Association [10]. In
general the Declaration contains guidelines for require-
ment prior to initiation of any research, while the research
is being conducted and after its completion and the pub-
lication of the project and its results. When research is car-
ried out on human beings the interest of the society (gain
of knowledge) must be weighed in proportion to the
interest of the research subject to safeguard his/her integ-
rity and not endanger or risk life or health. The most
important feature of the Declaration is the duty of the
researcher working with the test subjects; to safeguard the
health of the involved parties above all else (article 2 and
3).
Research Ethics Committees
Article 13 sets down the procedural guidelines for
Research Ethics Committees (REC) and states that
research projects must always seek ethical approval before
initiation of a project.
Most of the European countries have RECs at a national
level, examples of which are described in [5] (Sweden,
Lithuania, the Netherlands, Germany, The UK, Portugal,
Ireland, Denmark, France, Estonia and the Slovak Repub-
lic) [6].
The structure of the institutions approving biomedical
activity differs yet they for the most part respect the Hel-
sinki Declaration. In Denmark regional committees are
placed in each of the five regions and each includes 12–20
members, half of which are lay persons and the rest health
personnel. In Germany there are about 150 regional ethics
committees, each including 12–20 widely multidiscipli-
nary members. On Cyprus the National Bioethics Com-
mittee is the institution which shall approve the
biomedical activities. It is an independent body and
includes 13 multidisciplinary members, who are
appointed directly by the Council of Ministers for 4-year
term. To assist with the evaluation of proposals the
National Committee has appointed two 9-members
Bioethics Evaluation Committees. And in Belgium ethics
committees are associated with universities or hospitals,
mostly including biomedical professionals, in some com-
mittees maybe also one or two philosophers or lay per-
sons.
Data protection
Data protection and communication of study findings are
essential issues concerning HBM as also stated in several
of the papers in this supplement issue of Environmental
Health [11-14]. In 1995 the Data Protection Directive 95/
46/EC was addressed to the Member States of the Euro-
pean Union http://www.cdt.org/privacy/eudirective/
EU_Directive_.html. The purpose of this Directive is to
protect the fundamental rights and freedoms of natural
persons and in particular their right to privacy with respect
to the processing of personal data. Informed consent is
one of the key components in the Directive and the
requirement of obtaining consent has been implemented
in all of the above mentioned countries. Withdrawal of
consent is not always stated in the Data Protection Act
(e.g. in the Netherlands, Germany, Portugal and Slovakia
[6]), but it must be assumed that withdrawal may take
place at any time during biomedical research. Data
processing is a detailed area of data protection and all
countries have implemented the provision and guidelines
from the Data Protection Directive.
Communication of results
Environmental Health aspects are predominant with
HBM and special attention should be devoted to societal
issues as discussed in [15], communication of results as
discussed by Keune et al [16] in relation to the Flemish
biomonitoring program and by Arendt [11] in relation to
breastfeeding and measurements of critical levels in the
breast milk. The benefit from breastfeeding with essential
supplies to the newborn must be weighed towards poten-
tial risks. Interpretation of HBM data related to risk has
been discussed internationally and by Boogard et al [17].
The"right to know" may challenge as participants in a bio-
medical research projects always have the right to acquire
information and the researchers have a duty to inform the
participants about the information necessary. The partici-
pant also has the "right NOT to know", which may be dif-
ficult to satisfy if much communication is by feed-back to
participants.Environmental Health 2008, 7(Suppl 1):S1 http://www.ehjournal.net/content/7/S1/S1
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Children
The workshop was a continuation of a stakeholder meet-
ing in Brussels organised by the DG environment of EU,
described by Sepai et al [18] where stakeholders in human
biomonitoring from industry, government, research and
NGOs also were asked about opinions on organisation of
biomonitoring studies including children:
￿ Enrolment could either be through direct approaches to
parents or advertisements.
￿ Repeated measurements were fully acceptable by all and
the majority accepted all samplings of blood, urine, scalp
hair and the questionnaire.
￿ Study persons should be informed about study results or
be given the opportunity to request results. Data should
be protected by coding and made available for govern-
ments and research after anonymisation.
￿ Reimbursement of expenses related to participation
should be organised while different views were expressed
regarding incentives as gifts and payment.
￿ National differences in regulation should be respected
while harmonisation was considered a necessity for future
HBM activities.
Conclusions and recommendations
Conclusions and recommendations from the workshop
to be brought forward to the European projects that hope-
fully will be initiated soon were:
￿ Protocols need to be developed covering common issues
for all participants in collaborative HBM studies, declar-
ing the study aims and specific hypotheses, the study pop-
ulations and differences related to environmental
exposures – background levels, spot exposures, vulnerable
populations
The protocol should also describe methods to be used in:
- Selection and recruitment of study persons (special issue
with children – directly via family or through schools),
- Sampling (which media and how much) and
- Processing and storage of samples, analysis
- Results and results interpretation
- Information strategy prior, while and after study
Special attention must be given to the informed consent
with elements of
￿ Information about study
￿ Procedures (sampling, questionnaire, monitoring, fol-
low-up, data protection)
￿ Sign to participation in separate parts
￿ Agree to store samples and biobanking/future uses
￿ Agree to use samples for purposes of environmental
health studies
￿ Agree to share results with other researchers, policy mak-
ers
Finally the workshop addressed the common issue of
biobanking which implies thorough information of par-
ticipants, reporting of study results and potential other
uses, insurance of data protection but opportunities of
data sharing and follow-up to fully exploit study material
and to avoid unnecessary repeats of samplings.
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